Clive Glover, PhD

Business Leader, Viral Vectors at Cytiva

Speaker

Clive leads the viral vector business unit at Cytiva and has been involved with setting the strategy around this fast-growing area, including investments and acquisitions. Most recently, he led the acquisition and integration of Precision Nanosystems, a company involved in the lipid nanoparticle space. Previously, he was responsible for driving product development efforts around cell therapy at GE Healthcare and held positions in marketing and product management at STEMCELL Technologies. Clive holds a PhD in Genetics from the University of British Columbia.